|4Jan 21, 8:58 PM ET

Wang Theodore T 4

4 · EKSO BIONICS HOLDINGS, INC. · Filed Jan 21, 2020

Insider Transaction Report

Form 4
Period: 2020-01-16
Wang Theodore T
Director10% Owner
Transactions
  • Award

    Common Stock

    2020-01-16$0.45/sh+19,445$8,75038,624 total
  • Award

    Stock Option (right to buy)

    2020-01-16+136,496136,496 total
    Exercise: $0.38Exp: 2030-01-16Common Stock (136,496 underlying)
Holdings
  • Common Stock

    (indirect: By LLC)
    20,534,898
Footnotes (2)
  • [F1]These securities are held directly by Puissance Cross-Border Opportunities II LLC and may be deemed to be beneficially owned by Puissance Capital Management LP, the investment manager of Puissance Cross Border Opportunities II LLC; Puissance Capital Management (GP) LLC, the general partner of Puissance Capital Management LP; Puissance Capital Fund (GP) LLC, the general partner of Puissance Cross Border Opportunities II LLC; and Theodore T. Wang, the managing member of Puissance Capital Management (GP) LLC and Puissance Capital Fund (GP) LLC. The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein. This report shall not be deemed an admission that the Reporting Person is the beneficial owner of the reported securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.
  • [F2]The option vests and becomes exercisable in 12 equal monthly installments beginning on the one-month anniversary of July 1, 2019.

Documents

2 files